Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 purchases).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $1.3M | SEC | ||
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $132.7K | SEC | ||
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $490.8K | SEC | ||
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $3.3M | SEC | ||
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $6.6M | SEC | ||
enGene Therapeutics Inc.Listing on record | Buy | $5M | conv 69ClusterFirst in 12mo | SEC | |
Forbion European Acquisition Corp.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Forbion European Acquisition Corp.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Forbion European Acquisition Corp.Listing unverified | AwardD (derivative) | $1.5M | SEC |